The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Bora Pharmaceuticals Co's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.00.
The historical rank and industry rank for Bora Pharmaceuticals Co's Dividend Payout Ratio or its related term are showing as below:
TPE:6472'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.08 Med: 0.36 Max: 1.4
Current: 0.35
During the past 13 years, the highest Dividend Payout Ratio of Bora Pharmaceuticals Co was 1.40. The lowest was 0.08. And the median was 0.36.
TPE:6472's Dividend Payout Ratio is ranked better than 55.63% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs TPE:6472: 0.35
During the past 13 years, the highest Trailing Annual Dividend Yield of Bora Pharmaceuticals Co was 3.37%. The lowest was 0.23%. And the median was 1.00%.
During the past 12 months, Bora Pharmaceuticals Co's average Dividends Per Share Growth Rate was 16.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 78.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 83.80% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 63.60% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bora Pharmaceuticals Co was 104.70% per year. The lowest was 2.00% per year. And the median was 84.45% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Bora Pharmaceuticals Co (TPE:6472) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Bora Pharmaceuticals Co Dividend Payout Ratio Related Terms
Bora Pharmaceuticals Co Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Bora Pharmaceuticals Co's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bora Pharmaceuticals Co Dividend Payout Ratio Chart
TPE:6472 vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Bora Pharmaceuticals Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bora Pharmaceuticals Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bora Pharmaceuticals Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Bora Pharmaceuticals Co's Dividend Payout Ratio falls into.
Bora Pharmaceuticals Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Bora Pharmaceuticals Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bora Pharmaceuticals Co (TPE:6472) has a Dividend Payout Ratio of 0.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bora Pharmaceuticals Co and its competitors. Over the past decade, Bora Pharmaceuticals Co's Dividend Payout Ratio has ranged from 0.08 to 1.40. According to the industry distribution chart, Bora Pharmaceuticals Co ranks #197 out of 444 companies in the Drug Manufacturers industry, placing it in the top 44.4%.
Is Bora Pharmaceuticals Co's Dividend Payout Ratio too high?
Bora Pharmaceuticals Co's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 1.40. Based on the distribution chart, Bora Pharmaceuticals Co ranks #197 out of 444 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Bora Pharmaceuticals Co has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bora Pharmaceuticals Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Bora Pharmaceuticals Co ranks #197 out of 444 companies for Dividend Payout Ratio. This puts Bora Pharmaceuticals Co in the upper half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, Bora Pharmaceuticals Co's own Dividend Payout Ratio has ranged from 0.08 to 1.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bora Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bora Pharmaceuticals Co's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bora Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Bora Pharmaceuticals Co (TPE:6472) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$716.94, compared to a current price of NT$439.50 — trading 38.7% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Bora Pharmaceuticals Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Bora Pharmaceuticals Co (TPE:6472), the current Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bora Pharmaceuticals Co (TPE:6472) Overvalued in 2026?
Based on GuruFocus' analysis, Bora Pharmaceuticals Co stock appears to be undervalued.
The current stock price of NT$439.50 is trading 38.7% below its estimated GF Value™ of NT$716.94.
GuruFocus considers Bora Pharmaceuticals Co to be Significantly Undervalued.
Key valuation signals for TPE:6472:
Dividend Payout Ratio: 0.00
GF Value™: NT$716.94 vs. price of NT$439.50 (38.7% below fair value)
No single metric tells the full story. See the TPE:6472 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Sales segment: sale of pharmaceuticals, generics, and healthcare products. CDMO segment: contract development and manufacturing organization of pharmaceuticals. Other segment: Others. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.
87GF Score
Get the complete analysis for TPE:6472
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6472 has been successfully added to your 
